We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

2 hedge funds and large institutions have $27K invested in Bioverativ Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 449 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 459 → 2 (-457)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 449

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $5.76B → $27K (-$5.76B)

Holders
2
Holders Change
-457
Holders Change %
-99.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
449
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACS
Archford Capital Strategies
Illinois
+$2.28K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$585M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$497M
3
Primecap Management
Primecap Management
California
-$411M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$274M
5
State Street
State Street
Massachusetts
-$232M
Name Holding Trade Value Shares
Change 		Change in
Stake
BTS
251
BB&T Securities
Virginia
– -$363K -6,747 Closed
OPPM
252
Opus Point Partners Management
New York
– -$361K -6,689 Closed
CPA
253
Court Place Advisors
Maryland
– -$354K -6,567 Closed
Zurich Cantonal Bank
254
Zurich Cantonal Bank
Switzerland
– -$331K -6,136 Closed
RJT
255
Raymond James Trust
Florida
– -$328K -6,072 Closed
OI
256
Oakbrook Investments
Illinois
– -$316K -5,856 Closed
CCP
257
Cardan Capital Partners
Colorado
– -$310K -5,762 Closed
BC
258
Burney Company
Virginia
– -$309K -5,739 Closed
Marshall Wace
259
Marshall Wace
United Kingdom
– -$305K -5,664 Closed
OA
260
Oak Associates
Ohio
– -$287K -5,315 Closed
IHL
261
Investment House LLC
California
– -$284K -5,266 Closed
KAM
262
Kazazian Asset Management
Florida
– -$280K -5,201 Closed
MLIC
263
Mandatum Life Insurance Company
Finland
– -$275K -5,102 Closed
WTC
264
WhitTier Trust Company
Nevada
– -$272K -5,043 Closed
FBC
265
Fairfield, Bush & Co
Connecticut
– -$270K -5,000 Closed
HIIFS
266
Harel Insurance Investments & Financial Services
Israel
– -$270K -5,000 Closed
CIBC Asset Management
267
CIBC Asset Management
Ontario, Canada
– -$263K -4,885 Closed
Fayez Sarofim & Co
268
Fayez Sarofim & Co
Texas
– -$262K -4,856 Closed
SCM
269
Stevens Capital Management
Pennsylvania
– -$250K -4,635 Closed
ECM
270
Estabrook Capital Management
New York
– -$243K -4,500 Closed
RCAG
271
Rehmann Capital Advisory Group
Michigan
– -$241K -4,478 Closed
ACI
272
AMP Capital Investors
Australia
– -$241K -4,466 Closed
LWCFA
273
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
– -$229K -4,241 Closed
AT
274
Arden Trust
Delaware
– -$226K -4,185 Closed
TCM
275
Traynor Capital Management
Pennsylvania
– -$222K -4,131 Closed
9 10
11
12 13

BIVV Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2018, worth a combined $27K — down 100% from $5.76B a quarter earlier.

Sellers outnumbered buyers: 449 funds closed out of BIVV and 1 opened new positions — a net loss of 448 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Archford Capital Strategies, opening a new position worth an estimated $2.28K. The largest seller was BlackRock, exiting entirely with an estimated $585M sold.

  • 2 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2018, down from 459 in Q4 2017.
  • Funds reported $27K of Bioverativ Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Bioverativ Inc. Common Stock positions in Q1 2018 and 449 closed out, a net change of -448 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2018 was Archford Capital Strategies, an estimated $2.28K added.
  • The largest Bioverativ Inc. Common Stock seller in Q1 2018 was BlackRock, an estimated $585M sold.

Based on aggregated 13F filings for Q1 2018.